Fidelity® MSCI Health Care ETF (FHLC)

45.14 +1.01  +2.29% NYSE Arca Apr 7, 09:32 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 44.20
Discount or Premium to NAV -0.16%
Turnover Ratio 5.00%
1 Year Fund Level Flows -64.81M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -6.16% -6.09% -11.87% 26
3M -10.65% -10.46% -16.05% 45
6M 2.62% 2.74% -0.15% 62
YTD -10.68% -10.52% -16.89% 42
1Y 0.27% 0.36% -7.80% 37
3Y 9.25% 9.33% 5.33% 27
5Y 6.51% 6.55% 2.42% 22
10Y -- -- 11.97% --
15Y -- -- 10.25% --
20Y -- -- 8.37% --
As of April 6, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.28% 0.28% 0.00%
Stock 99.72% 99.72% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of April 3, 2020

Region Exposure

Americas 98.17%
North America 98.16%
Latin America 0.01%
Greater Europe 1.82%
United Kingdom 0.20%
Europe Developed 1.62%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.09%
As of April 3, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.01%
Healthcare 99.93%
Industrials 0.02%
Real Estate 0.00%
Technology 0.04%
Utilities 0.00%
As of April 3, 2020

Stock Market Capitalization

Giant 49.52%
Large 32.34%
Medium 12.82%
Small 4.74%
Micro 0.58%
As of April 3, 2020

Stock Style Exposure

Large Cap Value 27.12%
Large Cap Blend 40.33%
Large Cap Growth 14.74%
Mid Cap Value 1.92%
Mid Cap Blend 3.46%
Mid Cap Growth 7.42%
Small Cap Value 0.48%
Small Cap Blend 1.13%
Small Cap Growth 3.40%
As of April 3, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 9.34% 139.98 +0.16%
UNH UnitedHealth Group Inc 5.75% 265.00 +6.71%
MRK Merck & Co Inc 5.13% 81.10 +0.98%
PFE Pfizer Inc 4.92% 34.84 +0.78%
ABT Abbott Laboratories 3.72% 84.13 +1.69%
BMY Bristol-Myers Squibb Company 3.44% 58.40 +0.92%
AMGN Amgen Inc 3.23% 212.50 +0.43%
LLY Eli Lilly and Co 3.19% 142.60 +0.70%
MDT Medtronic PLC 3.06% 100.94 +7.28%
TMO Thermo Fisher Scientific Inc 2.99% 310.82 +2.24%
As of April 3, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care Index. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name Fidelity Investments
Benchmark Index
MSCI USA IMI/Health Care GR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Alan Mason 3.75 yrs
Amy Whitelaw 1.33 yrs
Greg Savage 6.20 yrs
Jennifer Hsui 6.20 yrs
Rachel Aguirre 1.33 yrs

Net Fund Flows

1M -64.41M
3M -3.173M
6M 49.43M
YTD -3.173M
1Y -64.81M
3Y 652.71M
5Y 812.95M
10Y --
As of March 31, 2020

Risk Info

Beta (5Y) 0.8486
Max Drawdown (All) 28.74%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.793
30-Day Rolling Volatility 72.36%
Daily Value at Risk (VaR) 1% (All) 3.13%
Monthly Value at Risk (VaR) 1% (All) 10.70%

Fundamentals

Dividend Yield TTM (4-7-20) 1.51%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 20.72
Weighted Average Price to Sales Ratio 1.730
Weighted Average Price to Book Ratio 3.671
Weighted Median ROE 21.40%
Weighted Median ROA 7.14%
Forecasted Dividend Yield 1.84%
Forecasted PE Ratio 14.79
Forecasted Price to Sales Ratio 1.572
Forecasted Price to Book Ratio 3.509
Number of Holdings 359
As of April 3, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.43%
Forecasted Book Value Growth 4.26%
Forecasted Cash Flow Growth 9.98%
Forecasted Earnings Growth 17.76%
Forecasted Revenue Growth 9.96%
As of April 3, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 10/21/2013
Termination Date
Last Annual Report Date 7/31/2019
Last Prospectus Date 11/29/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.